Please check your internet connection and try again.
# Calcium Gluconate
## Overview
Calcium gluconate is a calcium salt (approx. 9% elemental calcium) used for the treatment of hypocalcemia and as a cardioprotective agent in hyperkalemia. It is preferred over calcium chloride for peripheral administration to reduce the risk of tissue necrosis.
## Primary Indications
* Acute symptomatic hypocalcemia.
* Cardiac membrane stabilization in hyperkalemia.
* Calcium channel blocker or magnesium toxicity.
## Adult Dosing
* **Hypocalcemia:** 1–2 g IV administered over 10–20 minutes. May repeat every 4–6 hours as needed based on serum levels.
* **Hyperkalemia/Cardioprotection:** 1–2 g IV push over 5–10 minutes. May repeat after 5 minutes if ECG changes persist.
* **Max Rate:** Not to exceed 200 mg/minute (2 mL/minute of 10% solution) to prevent cardiac arrhythmias.
## Pediatric Dosing
* **Hypocalcemia:** 50–100 mg/kg/dose (0.5–1 mL/kg of 10% solution) IV slow bolus over 10–20 minutes.
* **Hyperkalemia:** 50–100 mg/kg/dose IV slow bolus.
* *Note: Cardiac monitoring is mandatory during infusion; doses must be adjusted based on local institutional protocols.*
## Dose Adjustments
* **Renal Impairment:** No standard dosage adjustment; however, use with extreme caution in patients with hyperphosphatemia, as calcium-phosphate precipitation may occur.
* **Hepatic Impairment:** No adjustment required.
## Contraindications
* Ventricular fibrillation.
* Hypercalcemia.
* Digitalis toxicity (relative contraindication; calcium may precipitate severe arrhythmias).
## Adverse Effects
* **Injection site:** Tissue necrosis/sloughing if extravasation occurs (manage with hyaluronidase).
* **Cardiovascular:** Bradycardia, syncope, hypertension, or arrhythmia (if infused too rapidly).
* **GI:** Chalky taste, nausea, or vomiting during infusion.
## Key Drug Interactions
* **Ceftriaxone:** Concurrent use with calcium in neonates (<28 days) is absolutely contraindicated due to fatal precipitation.
* **Digoxin:** Calcium increases myocardial sensitivity to digitalis; may precipitate severe digitalis toxicity.
* **Phosphates:** Avoid concurrent IV delivery to prevent calcium-phosphate precipitation.
## Monitoring
* **ECG:** Continuous monitoring during IV administration; stop immediately if bradycardia or arrhythmias occur.
* **Electrolytes:** Ensure serum calcium and phosphorus concentrations are checked regularly.
* **Site:** Carefully monitor the injection site for infiltration.
## Clinical Pearls
* **Administration:** Ensure patency of the IV line before administration. Use a large vein; central line preferred, but peripheral is acceptable if delivery is slow.
* **Elemental Calcium:** 1 g of calcium gluconate = 90 mg (4.65 mEq) of elemental calcium.
* **Compatibility:** Highly incompatible with many drugs; flush lines thoroughly before/after administration. Do not mix with sodium bicarbonate.
***
*Educational Disclaimer: This information is for educational purposes only. Always consult current institutional protocols and verify dosages/compatibility using primary references (e.g., Lexicomp, UpToDate) before prescribing or administering medication.*